skip to main
|
skip to sidebar
Blog Archives: Nov 2004 - present
Special items: Ovarian Cancer and Us blog best viewed in Firefox
Medscape
Commenting by email, Dr. Milan J. Anadkat of Washington University
School of Medicine, St. Louis, Missouri, told Reuters Health, "Our
understanding of dermatologic toxicity from targeted chemotherapies
continue to evolve. Early results with anti-PD1/PDL1 therapy have shown
considerable promise on the oncology landscape."
Dr.
Anadkat, whose research interests include chemotherapy-induced skin
reactions, concluded, "The consistent finding of lichenoid dermatitis in
patients who experienced rash on these therapies are an important
finding by Dr. Choi's group."
Lichenoid disorders
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.